(All fields required)
Please enter a valid email.
Please enter your name.
In early-stage studies, combining mTOR inhibitors with chemotherapy appears far more effective against T-cells acute lymphoblastic leukemia (T-ALL) than stand-alone treatment. Read More.
In mouse models, combining rapamycin and progesterone reduced preterm births.Read More »
Inhibiting the FoxM1 protein may offer a novel way to attack prostate cancer.Read More »
Research team develops antibody to preventCandida from binding with heparin.Read More »
The transcription factor RUNX1 plays unexpected role in supporting AML growth.Read More »
NGAL biomarker test successfully diagnoses acute kidney injury in emergency settings.Read More »
A molecular process that causes a genetic form of deafness also may increase risks for damage to the heart, thyroid and salivary glands.Read More »
Register today for Pediatric Insights, our monthly e-newsletter for physicians. Receive the latest information on clinical advancements, research updates and news from Cincinnati Children's.
Subscribe Now >>
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center